Literature DB >> 32249733

Prescribed Drug Spending in Canada, 2019: A Focus on Public Drug Programs.

Kathy Lee1, Trupti Jani2, Roger Cheng3, Jordan Hunt4.   

Abstract

Public drug program spending accounts for 43.1% of prescribed drug spending in Canada. This report provides an in-depth look at public drug program spending in Canada, using the Canadian Institute for Health Information's (CIHI) National Prescription Drug Utilization Information System. Public drug program spending does not include spending on drugs dispensed in hospitals or on those funded through cancer agencies and other special programs.
Copyright © 2020 Longwoods Publishing.

Entities:  

Year:  2020        PMID: 32249733     DOI: 10.12927/hcq.2020.26145

Source DB:  PubMed          Journal:  Healthc Q        ISSN: 1710-2774


  2 in total

1.  Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study.

Authors:  Mei Wang; Michael Paterson; Lehana Thabane; Deborah Siegal; Lawrence Mbuagbaw; Laura Targownik; Anne Holbrook
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

2.  Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study.

Authors:  Anat Fisher; Jason D Kim; Colin R Dormuth
Journal:  CMAJ Open       Date:  2022-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.